AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G] Ginkgo Bioworks Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:07/29/2025
Ginkgo Bioworks Holdings Inc

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Latest SEC Filings

DNA Stock Data

731.12M
55.40M
6.77%
79.18%
13.94%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
BOSTON